LAIGO BIO
LIVE

Serial Number

79353322

Owner

Laigo Bio B.V.

Attorney

Elizabeth A. Cominolli

Filing Date

Sep 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

LAIGO BIO Trademark

Serial Number: 79353322 • Registration: 7220678

LAIGO BIO is a trademark filed by Laigo Bio B.V. on September 28, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Laigo Bio B.V. (2 trademarks)

Jaarbeursplein 6

Entity Type: 26

Trademark Details

Filing Date

September 28, 2022

Registration Date

November 21, 2023

Published for Opposition

September 5, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 18, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 21, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 21, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Sep 4, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 16, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 16, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 27, 2023 TROA
REFUSAL PROCESSED BY IB
May 2, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2023 RFCR
NON-FINAL ACTION WRITTEN
Feb 18, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 17, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 20, 2022 REPR